Literature DB >> 2711203

Experimental antitumor activity of Navelbine.

S Cros1, M Wright, M Morimoto, H Lataste, J P Couzinier, A Krikorian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2711203

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  23 in total

Review 1.  A review of the antitumour activity of vinorelbine in breast cancer.

Authors:  M Marty; J M Extra; V Dieras; S Giacchetti; S Ohana; M Espié
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  Overview of new treatments for breast cancer.

Authors:  G N Hortobagyi
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Efficacy of vinorelbine-based neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Hui Gao; Qiuyun Li; Wei Wei; Y I Jiang; Huawei Yang; Jianlun Liu
Journal:  Mol Clin Oncol       Date:  2015-06-09

4.  Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.

Authors:  Kaisa Erjala; Misa Raitanen; Jarmo Kulmala; Reidar Grénman
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-05       Impact factor: 4.553

5.  Cisplatin plus continuous infusion vinorelbine for the treatment of advanced non-small cell lung cancer: a phase I-II study.

Authors:  M Cobo-Dols; S Gil-Calle; E Villar-Chamorro; I Alés-Díaz; F Carabantes-Ocón; J Alcalde-García; V Gutiérrez-Calderón; A Montesa-Pino; J J Bretón-García; M Benavides-Orgaz
Journal:  Clin Transl Oncol       Date:  2006-07       Impact factor: 3.405

Review 6.  Clinical pharmacokinetics of vinorelbine.

Authors:  D Levêque; F Jehl
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 7.  Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.

Authors:  K L Goa; D Faulds
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

8.  Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma. A phase II study.

Authors:  A Testolin; G Recher; V Cristoferi; G Gasparini
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

Review 9.  Preclinical and clinical pharmacology of vinca alkaloids.

Authors:  X J Zhou; R Rahmani
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 10.  The current and future place of vinorelbine in cancer therapy.

Authors:  E Cvitkovic; J Izzo
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.